Followers | 43 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |
Thursday, October 13, 2022 7:50:17 AM
Blue Water Vaccines Down 38% After Wednesday Surge
By Josh Beckerman
Blue Water Vaccines Inc. shares were down 38% at $4.74, a day after nearly tripling on news that the company is exploring use of its virus-like particle platform for a monkeypox vaccine candidate.
The stock closed at $2.55 Tuesday and $7.64 Wednesday.
Blue Water's operations include development of a universal flu vaccine to provide protection from all virulent strains. When it reported second-quarter results on Monday, the company said it believes its cash and cash equivalents are sufficient to fund operations through 2024.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
August 18, 2022 12:49 ET (16:49 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.”
my posts are always theory and not financial advice
Recent ONCO News
- Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors • GlobeNewswire Inc. • 02/13/2024 11:00:00 AM
- Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™ • GlobeNewswire Inc. • 12/18/2023 12:00:00 PM
FEATURED Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • Apr 16, 2024 8:52 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM
Avant Technologies Begins Development on Next-Generation AI-Driven Resource Allocation Solution • AVAI • Apr 16, 2024 8:00 AM
UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM